Cargando…

P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC)

BACKGROUND: P2X7, a purinergic receptor, plays important roles in inflammatory diseases, but recently its expression has been found in several tumors, suggesting a potential role as a cancer cell biomarker. Moreover, the relative amount of P2X7 varies among human individuals due to numerous single n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boldrini, Laura, Giordano, Mirella, Alì, Greta, Servadio, Adele, Pelliccioni, Serena, Niccoli, Cristina, Mussi, Alfredo, Fontanini, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158335/ https://www.ncbi.nlm.nih.gov/pubmed/25178922 http://dx.doi.org/10.1186/1477-5751-13-16

Ejemplares similares

Prognostic role of TPL2 in early-stage non-small cell lung cancer
por: Boldrini, Laura, et al.
Publicado: (2017)

Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma
por: Boldrini, Laura, et al.
Publicado: (2017)

P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value
por: BOLDRINI, LAURA, et al.
Publicado: (2015)

Phosphatidylinositol-3-kinase α catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumours
por: CAPODANNO, ALESSANDRA, et al.
Publicado: (2012)

Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report
por: ALÌ, GRETA, et al.
Publicado: (2015)

Expression of miRNA-25 in young and old lung adenocarcinoma
por: Boldrini, Laura, et al.
Publicado: (2021)

Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients
por: Boldrini, Laura, et al.
Publicado: (2018)

Glomus tumor of the shoulder: A case report and review of the literature
por: PROIETTI, AGNESE, et al.
Publicado: (2013)

Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas
por: Fontanini, G, et al.
Publicado: (1999)

KRAS and BRAF genotyping of synchronous colorectal carcinomas
por: GIANNINI, RICCARDO, et al.
Publicado: (2014)

Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer
por: Boldrini, L, et al.
Publicado: (2005)

Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis
por: Bruno, Rossella, et al.
Publicado: (2016)

Tumour necrosis factor- α and transforming growth factor- β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL -2-mediated neovascularization
por: Boldrini, L, et al.
Publicado: (2000)

A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma
por: Fontanini, G, et al.
Publicado: (2002)

miR-19a and miR-20a and Tissue Factor Expression in Activated Human Peripheral Blood Mononuclear Cells
por: Balia, Cristina, et al.
Publicado: (2017)

New Immunohistochemical Markers for Pleural Mesothelioma Subtyping
por: Di Stefano, Iosè, et al.
Publicado: (2023)

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer.
por: Fontanini, G., et al.
Publicado: (1995)

Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
por: Fontanini, G., et al.
Publicado: (1997)

Cross talk between the bombesin neuropeptide receptor and Sonic hedgehog pathways in small cell lung carcinoma
por: Castellone, Maria Domenica, et al.
Publicado: (2014)

Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non–Small Cell Lung Cancer (NSCLC): a Brief Report of 7 Cases()
por: Scattone, Anna, et al.
Publicado: (2018)

Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer
por: Poma, Anello Marcello, et al.
Publicado: (2021)

The Polymorphism and Expression of EGFL7 and miR-126 Are Associated With NSCLC Susceptibility
por: Liu, Weipeng, et al.
Publicado: (2022)

Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact
por: Alì, G, et al.
Publicado: (2009)

Different pathological response and histological features following neoadjuvant chemotherapy or chemo-immunotherapy in resected non-small cell lung cancer
por: Alì, Greta, et al.
Publicado: (2023)

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin
por: Tiseo, M, et al.
Publicado: (2013)

Robotic versus Open Surgery in Locally Advanced Non-Small Cell Lung Cancer: Evaluation of Surgical and Oncological Outcomes
por: Zirafa, Carmelina C., et al.
Publicado: (2023)

Feasibility of BRCA1/2 Testing of Formalin-Fixed and Paraffin-Embedded Pancreatic Tumor Samples: A Consecutive Clinical Series
por: Bruno, Rossella, et al.
Publicado: (2021)

Staging of non-small cell lung cancer (NSCLC)
por: Rankin, S C
Publicado: (2006)

SMARCA4 as a support for the differential diagnosis of poorly differentiated lung carcinomas
por: Panozzi, Martina, et al.
Publicado: (2023)

p53 and angiogenesis in non-small-cell lung cancer: Reply to the letter from Giatromanolaki and Koukourakis
por: Fontanini, G
Publicado: (1998)

Squamous cell transformation and EGFR T790M mutation as acquired resistance mechanisms in a patient with lung adenocarcinoma treated with a tyrosine kinase inhibitor: A case report
por: Bruno, Rossella, et al.
Publicado: (2017)

Next Generation Sequencing for Gene Fusion Analysis in Lung Cancer: A Literature Review
por: Bruno, Rossella, et al.
Publicado: (2020)

Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC
por: Zito Marino, Federica, et al.
Publicado: (2020)

ALK‐rearrangement in non‐small‐cell lung cancer (NSCLC)
por: Du, Xue, et al.
Publicado: (2018)

The Unknown Oldowan: ~1.7-Million-Year-Old Standardized Obsidian Small Tools from Garba IV, Melka Kunture, Ethiopia
por: Gallotti, Rosalia, et al.
Publicado: (2015)

CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9
por: He, Weiling, et al.
Publicado: (2018)

Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development
por: Sarogni, Patrizia, et al.
Publicado: (2019)

Advances in radiological staging of non-small cell lung cancer (NSCLC)
por: Rankin, S C
Publicado: (2004)

Mitochondrial Variations in Non-Small Cell Lung Cancer (NSCLC) Survival
por: Wang, Zhaoxi, et al.
Publicado: (2015)

ASCO 2020 non-small lung cancer (NSCLC) personal highlights
por: Horvath, Lena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n4d3gvid1eid2isns59mi1uf01